HOLY STONE HEALTHCARE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.05 TWD | -0.58% |
|
+0.29% | -12.89% |
| Sales 2022 | 270M 8.3M | Sales 2023 | 237M 7.28M | Capitalization | 2.41B 73.95M |
|---|---|---|---|---|---|
| Net income 2022 | -153M -4.7M | Net income 2023 | -289M -8.88M | EV / Sales 2022 | 12.5 x |
| Net cash position 2022 | 422M 12.96M | Net cash position 2023 | 8.77M 269K | EV / Sales 2023 | 10.1 x |
| P/E ratio 2022 |
-24
x | P/E ratio 2023 |
-9.23
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 37.51% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.58% | ||
| 1 week | +0.29% | ||
| 1 month | +0.59% | ||
| 3 months | -10.31% | ||
| 6 months | -27.69% | ||
| Current year | -12.89% |
1 week
16.60
17.65
1 month
16.4518.55
Current year
15.8521.04
1 year
15.8541.85
3 years
15.8546.99
5 years
8.7946.99
10 years
8.7970.28
| Managers | Title | Age | Since |
|---|---|---|---|
Tsung Chung Wu
CEO | Chief Executive Officer | - | 01-01-31 |
Yue Ling Liu
DFI | Director of Finance/CFO | - | 13-01-01 |
Ching Hua Yang
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jing Rong Tang
CHM | Chairman | - | 12-05-16 |
Ching Hua Yang
COO | Chief Operating Officer | - | - |
Kao Chung Tsai
BRD | Director/Board Member | 62 | 14-03-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 17.05 | -0.58% | 56,080 |
| 24-04-25 | 17.15 | -2.83% | 65,910 |
| 24-04-24 | 17.65 | +4.44% | 133,385 |
| 24-04-23 | 16.9 | +0.30% | 53,770 |
| 24-04-22 | 16.85 | -0.88% | 45,979 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes
Holy Stone Healthcare Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and wholesale of medical equipment. The Company's main products include latent tuberculosis infection test reagents, Ostenil branded joint cavity injection and other medical equipment. The Company is also involved in the manufacture of western medicines, as well as the research and development of new drugs and new medical materials. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -12.89% | 64.27M | |
| +25.83% | 661B | |
| +26.56% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.72% | 231B | |
| +5.27% | 200B | |
| -8.83% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4194 Stock
